Abbreviations used in this paper: GLP-1 glucagon-like peptide-1 GLP-1R GLP-1 receptor T2D type 2 diabetes mellitus GLP-1RA GLP-1R agonists GPCR G-protein coupled receptor cAMP cyclic adenosine monophosphate PKA protein kinase A FDA Food and Drug Administration LPS lipopolysaccharide ALI acute lung injury OVA ovalbumin Th2 CD4+ T-helper type 2 ILC2s group 2 innate lymphoid cells IL-33 interleukin-33 DC dendritic cells FEV 1 forced expiratory volume in one second FVC forced vital capacity Th2-high type 2 inflammation high Th2-low type 2 inflammation low BALF bronchoalveolar lavage fluid TSLP thymic stromal lymphopoietin NO nitric oxide DPP-IV dipeptidyl peptidase IV GATA-3 Glucagon-like peptide-1 receptor Agonist Treatment in Adult, obesity-replated, symptomatic asthma Footnotes Conflicts of interest: KN Cahill has served on scientific advisory boards for GlaxoSmithKline, Regeneron, Genentech, Sanofi, Novartis, and AztraZeneca and served as a consultant for Ribon Therapeutics and Verantos outside the submitted work
Vandamme (Ed.), Biotechnology of Vitamins, Pigments and Growth Factors (pp
Laser toning is particularly effective for treating melasma, age spots, and uneven skin color with minimal downtime and gradual, natural-looking results
With its ability to regulate blood sugar levels and aid in weight loss, Semaglutide has garnered attention as a
Cavazzana-Calvo, M
Eleven of the 20 companies in our cohort increased their average peak sale in this period of analysis, with, again, the most notable increases coming from those companies that have progressed new GLP-1/GIP assets to their late-stage pipeline
